Positive Preclinical Results Unveiled for DPH001
We’re delighted to share positive results from our recent preclini...
Disruptive Pharma announces DPH001 pipeline project
We are excited to announce that Disruptive Pharma is initiating the deve...
Welcome Holger Müller – Director of Business Development at Disruptive Pharma
Holger brings more than 20 years of experience in commercialization of p...
Welcome Malin Vågerö – Director R&D at Disruptive Pharma
As an excellent addition to team Disruptive Pharma we are now happy to a...
Disruptive Pharma raises 41 million SEK to develop pipeline project towards clinical stage
We have some exciting news to share just before the summer – Disruptive ...